1. Home
  2. AROW vs LXRX Comparison

AROW vs LXRX Comparison

Compare AROW & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arrow Financial Corporation

AROW

Arrow Financial Corporation

HOLD

Current Price

$34.13

Market Cap

547.8M

Sector

Finance

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$1.64

Market Cap

547.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AROW
LXRX
Founded
1851
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
547.8M
547.4M
IPO Year
1995
2000

Fundamental Metrics

Financial Performance
Metric
AROW
LXRX
Price
$34.13
$1.64
Analyst Decision
Hold
Buy
Analyst Count
1
5
Target Price
$28.00
$3.23
AVG Volume (30 Days)
71.4K
2.3M
Earning Date
04-30-2026
05-04-2026
Dividend Yield
3.59%
N/A
EPS Growth
N/A
21.25
EPS
1.80
N/A
Revenue
N/A
$31,081,000.00
Revenue This Year
$17.58
$56.61
Revenue Next Year
$5.21
N/A
P/E Ratio
$18.61
N/A
Revenue Growth
N/A
2481.48
52 Week Low
$22.72
$0.32
52 Week High
$36.44
$1.83

Technical Indicators

Market Signals
Indicator
AROW
LXRX
Relative Strength Index (RSI) 50.32 64.63
Support Level $31.06 $1.07
Resistance Level $34.57 $1.65
Average True Range (ATR) 0.94 0.10
MACD -0.22 0.02
Stochastic Oscillator 50.00 93.42

Price Performance

Historical Comparison
AROW
LXRX

About AROW Arrow Financial Corporation

Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of company's revenue is interest income, fees, commission earned through its subsidiaries.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: